Skip to main content
. Author manuscript; available in PMC: 2024 Jan 15.
Published in final edited form as: Curr Protoc. 2022 Jan;2(1):e355. doi: 10.1002/cpz1.355

Figure 69.

Figure 69.

Clicking a target point within the Parkinson’s Disease example, “Synaptogyrin-3” (SYNGR3) displays details including the full name and family of the target, Target Development Level (TDL), links to Pharos and DrugCentral, and, importantly, links to the associated two research articles (bottom).